Dr Seth Berkley, CEO, The GAVI Alliance.
This lecture is free and open to the public.
Dr Seth Berkley joined the GAVI Alliance (formerly the Global Alliance for Vaccines and Immunisation) as CEO in August 2011, as it launched its five year strategy to immunise a quarter of a billion children in the developing world with life-saving vaccines by 2015.
Prior to joining the GAVI Alliance (GAVI), Dr Berkley was the founder, president and CEO for 15 years of the International AIDS Vaccine Initiative ( IAVI ), the first vaccine product development public-private sector partnership. Under his leadership, IAVI implemented a global advocacy programme that assured that vaccines received prominent attention in the media and in forums such as the G 8, EU and the UN. He also oversaw the creation of a virtual vaccine product development effort involving industry, academia, and developing country scientists.
Prior to founding IAVI, Dr Berkley served as associate director in the Health Sciences Division at The Rockefeller Foundation. He has also worked for the Center for Infectious Diseases of the U. S. Centers for Disease Control and Prevention ( CDC ), the Massachusetts Department of Public Health and for the Carter Center where he served as an epidemiologist at the Ministry of Health in Uganda. He has consulted or worked in more than 25 countries in Asia, Africa and Latin America.
The GAVI Alliance is a unique public-private partnership of international organisations, donor governments, developing countries, vaccine manufacturers and civil society organisations, committed to protecting people’s health by increasing access to immunisation. Australia is supporting GAVI to provide life-saving immunisations in the world’s poorest countries. Every year nearly two million children die from vaccine-preventable diseases, mainly in developing countries. Immunisations not only save lives cost-effectively but promote health, allowing children to fully benefit from opportunities such as education.
GAVI, with Australia’s help, has supported the immunisation of over 325 million children against a variety of preventable diseases. Since 2006, Australia has provided $94 million to GAVI and has committed to provide an additional $140 million by 2013. With Australia’s support, GAVI has committed to rolling out the human papilloma virus (HPV) vaccine, to prevent cervical cancer amongst women in developing countries. Dr Berkley will discuss the role of immunisation in saving the lives and improving the health of women and children worldwide.